Rakuten Medical, Inc.
Rakuten Medical is developing the Alluminox® platform, an investigational platform based on photoimmunotherapy, to transform cancer treatments.
Funding history
About Rakuten Medical, Inc.
How much funding has Rakuten Medical, Inc. raised?
Rakuten Medical, Inc. has raised $225.9M in total funding. The most recent round was Series F.
Where is Rakuten Medical, Inc. headquartered?
Rakuten Medical, Inc. is headquartered in San Diego, CA.
What does Rakuten Medical, Inc. do?
Rakuten Medical is developing the Alluminox® platform, an investigational platform based on photoimmunotherapy, to transform cancer treatments.
What problem does Rakuten Medical, Inc. solve?
Cancer patients need better treatment options, regardless of nationality or wealth, and existing care can come too late, as described in the Executive Chairman's personal letter about his father.
What's Rakuten Medical, Inc.'s solution?
Rakuten Medical is developing drugs and devices based on its investigational Alluminox platform to bring new cancer treatments to market.
What makes Rakuten Medical, Inc. different?
Their core technology is photoimmunotherapy under the Alluminox platform, originally developed by Dr. Hisataka Kobayashi and team at the U.S. National Cancer Institute, with their lead candidate ASP-1929 presenting new clinical data at conferences like ASCO and AHNS.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
